Vireo Growth (VREOF) Receivables - Other (2021 - 2024)

Vireo Growth's (VREOF) quarterly Receivables - Other came in at $174660.0 in Q4 2024, little changed year-on-year from $174660.0 in Q1 2024, and down 96.66% quarter-over-quarter from $5.2 million in Q3 2024.

Vireo Growth (VREOF) Receivables - Other (2021 - 2024) Analysis & Trends

Vireo Growth has disclosed Receivables - Other across 3 years of filings, most recently posting $174660.0 for Q4 2024.

  • Receivables - Other for Q4 2024 came in at $174660.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2024 was $174660.0 (changed 0.0% YoY), and the FY2024 annual result was $174660.0, changed 0.0% from the prior year.
  • Receivables - Other came in at $174660.0 for Q4 2024 at Vireo Growth, down from $5.2 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $5.2 million in Q3 2024 to a low of $174660.0 in Q4 2023.
  • The 3-year median for Receivables - Other is $1.4 million (2023), against an average of $2.1 million.
  • Peak annual rise in Receivables - Other reached 289.97% in 2024, while the deepest fall reached 0.0% in 2024.
  • Vireo Growth's Receivables - Other stood at $191026.0 in 2021, then retreated by 8.57% to $174660.0 in 2023, then changed by 0.0% to $174660.0 in 2024.
  • The last three Receivables - Other figures came in at $174660.0 (Q4 2024), $5.2 million (Q3 2024), and $4.9 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Vireo Growth - - 59.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 174,660.00
Dec 31, 2024 174,660.00
Sep 30, 2024 5.22 Mn
Sep 30, 2024 5.22 Mn
Jun 30, 2024 4.87 Mn
Jun 30, 2024 4.87 Mn
Mar 31, 2024 3.27 Mn
Mar 31, 2024 3.27 Mn
Dec 31, 2023 174,660.00
Dec 31, 2023 174,660.00
Sep 30, 2023 1.57 Mn
Sep 30, 2023 1.57 Mn
Jun 30, 2023 1.25 Mn
Jun 30, 2023 1.25 Mn
Dec 31, 2021 191,026.00
Dec 31, 2021 191,026.00